BUSINESS
August 22, 1988 | United Press International
OVEX Fertility Corp. said it is engaged in preliminary talks concerning the acquisition of Selcore Laboratories Inc., a developer of vaccines. The discussions have proposed an acquisition using about 1.7 million shares of OVEX stock representing about 38% of the shares outstanding after the transaction.